A Special Recurrent Pattern in Small Hepatocellular Carcinoma After Treatment: Bile Duct Tumor Thrombus Formation

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2011 Dec 8

PMID 22147984

Citations 5

Authors

Qing-Yu Liu

Dong-Ming Lai

Chao Liu

Lei Zhang

Wei-Dong Zhang

Hai-Gang Li

Ming Gao

Affiliations

Soon will be listed here.

Abstract

Aim: To investigate the clinicopathologic features of bile duct tumor thrombus (BDTT) occurrence after treatment of primary small hepatocellular carcinoma (sHCC).

Methods: A total of 423 patients with primary sHCC admitted to our hospital underwent surgical resection or local ablation. During follow-up, only six patients were hospitalized due to obstructive jaundice, which occurred 5-76 mo after initial treatment. The clinicopathologic features of these six patients were reviewed.

Results: Six patients underwent hepatic resection (n = 5) or radio-frequency ablation (n = 1) due to primary sHCC. Five cases had an R1 resection margin, and one case had an ablative margin less than 5.0 mm. No vascular infiltration, microsatellites or bile duct/canaliculus affection was noted in the initial resected specimens. During the follow-up, imaging studies revealed a macroscopic BDTT extending to the common bile duct in all six patients. Four patients had a concomitant intrahepatic recurrent tumor. Surgical re-resection of intrahepatic recurrent tumors and removal of BDTTs (n = 4), BDTT removal through choledochotomy (n = 1), and conservative treatment (n = 1) was performed. Microscopic portal vein invasion was noted in three of the four resected specimens. All six patients died, with a mean survival of 11 mo after BDTT removal or conservative treatment.

Conclusion: BDTT occurrence is a rare, special recurrent pattern of primary sHCC. Patients with BDTTs extending to the common bile duct usually have an unfavorable prognosis even following aggressive surgery. Insufficient resection or ablative margins against primary sHCC may be a risk factor for BDTT development.

Citing Articles

A case of hepatocellular carcinoma arising from the intraductal hepatic bile duct without parenchymal lesion.

Nakashima Y, Hiramatsu K, Fukaya M, Aoba T, Arimoto A, Yamashita H Clin J Gastroenterol. 2024; 18(1):195-201.

PMID: 39433708 DOI: 10.1007/s12328-024-02054-2.

A nomogram based on combining systemic and hepatic inflammation markers for predicting microscopic bile duct tumour thrombus in hepatocellular carcinoma.

Wu J, Sun J, Wu J, Huang X, Bai Y, Zeng Y BMC Cancer. 2021; 21(1):272.

PMID: 33711965 PMC: 7955625. DOI: 10.1186/s12885-021-07956-9.

Extrahepatic bile duct hepatocellular carcinoma due to recurrence of hematogenous metastasis 50 months after hepatectomy.

Kumata H, Miyagi S, Murakami K, Fujio A, Hara Y, Nakanishi C Surg Case Rep. 2017; 3(1):30.

PMID: 28205184 PMC: 5311010. DOI: 10.1186/s40792-017-0305-3.

Bile duct thrombi in hepatocellular carcinoma: is aggressive surgery worthwhile?.

Rammohan A, Sathyanesan J, Rajendran K, Pitchaimuthu A, Perumal S, Balaraman K HPB (Oxford). 2015; 17(6):508-13.

PMID: 25639610 PMC: 4430781. DOI: 10.1111/hpb.12383.

Surgical outcomes of hepatocellular carcinoma with bile duct tumor thrombus: a Korean multicenter study.

Moon D, Hwang S, Wang H, Yun S, Kim K, Lee Y World J Surg. 2012; 37(2):443-51.

PMID: 23188531 DOI: 10.1007/s00268-012-1845-0.

References

Gabata T, Terayama N, Kobayashi S, Sanada J, Kadoya M, Matsui O . MR imaging of hepatocellular carcinomas with biliary tumor thrombi. Abdom Imaging. 2006; 32(4):470-4. DOI: 10.1007/s00261-006-9154-4. View

Shiomi M, Kamiya J, Nagino M, Uesaka K, Sano T, Hayakawa N . Hepatocellular carcinoma with biliary tumor thrombi: aggressive operative approach after appropriate preoperative management. Surgery. 2001; 129(6):692-8. DOI: 10.1067/msy.2001.113889. View

Jung A, Lee J, Choi S, Kim S, Lee J, Kim S . CT features of an intraductal polypoid mass: Differentiation between hepatocellular carcinoma with bile duct tumor invasion and intraductal papillary cholangiocarcinoma. J Comput Assist Tomogr. 2006; 30(2):173-81. DOI: 10.1097/00004728-200603000-00002. View

Peng B, Liang L, Li S, Zhou F, Hua Y, Luo S . Surgical treatment of hepatocellular carcinoma with bile duct tumor thrombi. World J Gastroenterol. 2005; 11(25):3966-9. PMC: 4504907. DOI: 10.3748/wjg.v11.i25.3966. View

Chen M, Jan Y, Jeng L, Hwang T, Wang C, Chen S . Obstructive jaundice secondary to ruptured hepatocellular carcinoma into the common bile duct. Surgical experiences of 20 cases. Cancer. 1994; 73(5):1335-40. DOI: 10.1002/1097-0142(19940301)73:5<1335::aid-cncr2820730505>3.0.co;2-m. View

Chen M, Li J, Zheng Y, Guo R, Liang H, Zhang Y . A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006; 243(3):321-8. PMC: 1448947. DOI: 10.1097/01.sla.0000201480.65519.b8. View

Liu Q, Chen J, Li H, Liang B, Zhang L, Hu T . Hepatocellular carcinoma with bile duct tumor thrombi: correlation of magnetic resonance imaging features to histopathologic manifestations. Eur J Radiol. 2009; 76(1):103-9. DOI: 10.1016/j.ejrad.2009.05.020. View

Adachi E, Maeda T, Matsumata T, Shirabe K, Kinukawa N, Sugimachi K . Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology. 1995; 108(3):768-75. DOI: 10.1016/0016-5085(95)90450-6. View

Lee K, Park J, Park J, Kim S, Choi S, Heo J . Liver transplantation for hepatocellular carcinoma with bile duct thrombi. Transplant Proc. 2006; 38(7):2093-4. DOI: 10.1016/j.transproceed.2006.06.034. View

10.

Shi M, Guo R, Lin X, Zhang Y, Chen M, Zhang C . Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg. 2007; 245(1):36-43. PMC: 1867934. DOI: 10.1097/01.sla.0000231758.07868.71. View

11.

Ezaki T, Koyanagi N, Yamagata M, Kajiyama K, Maeda T, Sugimachi K . Postoperative recurrence of solitary small hepatocellular carcinoma. J Surg Oncol. 1996; 62(2):115-22. DOI: 10.1002/(SICI)1096-9098(199606)62:2<115::AID-JSO7>3.0.CO;2-B. View

12.

Horigome H, Nomura T, Nakao H, Saso K, Takahashi Y, Akita S . Treatment of solitary small hepatocellular carcinoma: consideration of hepatic functional reserve and mode of recurrence. Hepatogastroenterology. 2000; 47(32):507-11. View

13.

Kumada T, Nakano S, Takeda I, Sugiyama K, Osada T, Kiriyama S . Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology. 1997; 25(1):87-92. DOI: 10.1053/jhep.1997.v25.pm0008985270. View

14.

Xiangji L, Weifeng T, Bin Y, Chen L, Xiaoqing J, Baihe Z . Surgery of hepatocellular carcinoma complicated with cancer thrombi in bile duct: efficacy for criteria for different therapy modalities. Langenbecks Arch Surg. 2009; 394(6):1033-9. DOI: 10.1007/s00423-009-0496-6. View

15.

Yeh C, Jan Y, Lee W, Chen M . Hepatic resection for hepatocellular carcinoma with obstructive jaundice due to biliary tumor thrombi. World J Surg. 2004; 28(5):471-5. DOI: 10.1007/s00268-004-7185-y. View

16.

Ng K, Poon R, Lo C, Yuen J, Tso W, Fan S . Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma. J Gastrointest Surg. 2007; 12(1):183-91. DOI: 10.1007/s11605-007-0276-y. View

17.

Petrowsky H, Busuttil R . Resection or ablation of small hepatocellular carcinoma: what is the better treatment?. J Hepatol. 2008; 49(4):502-4. DOI: 10.1016/j.jhep.2008.07.018. View

18.

Okuwaki Y, Nakazawa T, Shibuya A, Ono K, Hidaka H, Watanabe M . Intrahepatic distant recurrence after radiofrequency ablation for a single small hepatocellular carcinoma: risk factors and patterns. J Gastroenterol. 2008; 43(1):71-8. DOI: 10.1007/s00535-007-2123-z. View

19.

Peng S, Wang J, Liu Y, Cai X, Deng G, Xu B . Surgical intervention for obstructive jaundice due to biliary tumor thrombus in hepatocellular carcinoma. World J Surg. 2003; 28(1):43-6. DOI: 10.1007/s00268-003-7079-4. View

20.

Liu Q, Huang S, Chen J, Li H, Gao M, Liu C . Small hepatocellular carcinoma with bile duct tumor thrombi: CT and MRI findings. Abdom Imaging. 2009; 35(5):537-42. DOI: 10.1007/s00261-009-9571-2. View